“The Good, the Bad and the Ugly” in the First Year of COVID-19 Pandemic

During the first year of COVID-19 pandemic, while there have been rapid developments in diagnosis and treatment of the disease; drug interactions and side effects have created a problem especially in high risk patients with chronic diseases and multiple drug use. In contrast to the routine vaccine p...

Full description

Bibliographic Details
Main Authors: Berkay Kapar, Deniz Şimşek, Gülay Sain Güven
Format: Article
Language:English
Published: Bilimsel Tip Yayinevi 2021-03-01
Series:Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
Subjects:
Online Access:http://www.floradergisi.org/managete/fu_folder/2021-01/12-22%20Berkay%20Kapar.pdf
id doaj-9edb1f59b16945c98c610056a8e3c5c2
record_format Article
spelling doaj-9edb1f59b16945c98c610056a8e3c5c22021-04-15T09:15:00ZengBilimsel Tip YayineviFlora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi1300-932X1300-932X2021-03-01261122210.5578/flora.20219902“The Good, the Bad and the Ugly” in the First Year of COVID-19 PandemicBerkay Kapar0https://orcid.org/0000-0001-6458-3346Deniz Şimşek1https://orcid.org/0000-0001-5455-5667Gülay Sain Güven2https://orcid.org/0000-0001-8176-9767Department of Internal Diseases, Hacettepe University Faculty of Medicine Hospital, Ankara, TurkeyDepartment of Internal Diseases, Hacettepe University Faculty of Medicine Hospital, Ankara, TurkeyDepartment of Internal Medicine, Division of General İnternal Medicine, Hacettepe University Faculty of Medicine, Ankara, TurkeyDuring the first year of COVID-19 pandemic, while there have been rapid developments in diagnosis and treatment of the disease; drug interactions and side effects have created a problem especially in high risk patients with chronic diseases and multiple drug use. In contrast to the routine vaccine production process, SARS-CoV-2 vaccines have been developed in a short period of time by many pharmaceutical companies, and community vaccination has started in many countries. However, this process is restricted by mutation and problems in production and distribution. The fact that the pathophysiology of the disease has not been fully elucidated has brought the prolonged COVID-19 syndrome definition to our clinical practice. Positive improvements and negative aspects that we have encountered so far in the first year of this new pandemic reminded us the great film by Sergio Leone: “The Good, The Bad and The Ugly”. So, we decided to cover these aspects under the same headings. Gaining an overview of the many developments, problems and solution ideas we encountered and witnessed during the pandemic year will make the management of the process easier.http://www.floradergisi.org/managete/fu_folder/2021-01/12-22%20Berkay%20Kapar.pdfcovid-19sars-cov-2novel coronavirus
collection DOAJ
language English
format Article
sources DOAJ
author Berkay Kapar
Deniz Şimşek
Gülay Sain Güven
spellingShingle Berkay Kapar
Deniz Şimşek
Gülay Sain Güven
“The Good, the Bad and the Ugly” in the First Year of COVID-19 Pandemic
Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
covid-19
sars-cov-2
novel coronavirus
author_facet Berkay Kapar
Deniz Şimşek
Gülay Sain Güven
author_sort Berkay Kapar
title “The Good, the Bad and the Ugly” in the First Year of COVID-19 Pandemic
title_short “The Good, the Bad and the Ugly” in the First Year of COVID-19 Pandemic
title_full “The Good, the Bad and the Ugly” in the First Year of COVID-19 Pandemic
title_fullStr “The Good, the Bad and the Ugly” in the First Year of COVID-19 Pandemic
title_full_unstemmed “The Good, the Bad and the Ugly” in the First Year of COVID-19 Pandemic
title_sort “the good, the bad and the ugly” in the first year of covid-19 pandemic
publisher Bilimsel Tip Yayinevi
series Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
issn 1300-932X
1300-932X
publishDate 2021-03-01
description During the first year of COVID-19 pandemic, while there have been rapid developments in diagnosis and treatment of the disease; drug interactions and side effects have created a problem especially in high risk patients with chronic diseases and multiple drug use. In contrast to the routine vaccine production process, SARS-CoV-2 vaccines have been developed in a short period of time by many pharmaceutical companies, and community vaccination has started in many countries. However, this process is restricted by mutation and problems in production and distribution. The fact that the pathophysiology of the disease has not been fully elucidated has brought the prolonged COVID-19 syndrome definition to our clinical practice. Positive improvements and negative aspects that we have encountered so far in the first year of this new pandemic reminded us the great film by Sergio Leone: “The Good, The Bad and The Ugly”. So, we decided to cover these aspects under the same headings. Gaining an overview of the many developments, problems and solution ideas we encountered and witnessed during the pandemic year will make the management of the process easier.
topic covid-19
sars-cov-2
novel coronavirus
url http://www.floradergisi.org/managete/fu_folder/2021-01/12-22%20Berkay%20Kapar.pdf
work_keys_str_mv AT berkaykapar thegoodthebadandtheuglyinthefirstyearofcovid19pandemic
AT denizsimsek thegoodthebadandtheuglyinthefirstyearofcovid19pandemic
AT gulaysainguven thegoodthebadandtheuglyinthefirstyearofcovid19pandemic
_version_ 1721526458126434304